Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday.
Source: ABC News 6
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Published in Robesonia
More from RobesoniaMore posts in Robesonia »
- 6abc Dunkin' Holiday Food Drive Telethon raises over $81K
- Drunk raccoon found passed out in liquor store bathroom: Officials
- Former lab monkey finds new home at NJ animal refuge after surviving truck crash
- Philadelphia officer Andy Chan dies nearly 7 years after being critically injured in crash
- Surveillance video shows brazen heist at high-end boutique in New York City
Be First to Comment